Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis

International Journal of Antimicrobial Agents

Volumn 26, Issue 5, 2005, Pages 412-415

  Sipahi, Oguz Resat ^a   Arda, Bilgin ^a   Yurtseven, Taskin ^a   Sipahi, Hilal ^a   Ozgiray, Erkin ^a   Suntur, Bedia Mutay ^b   Ulusoy, Sercan ^a  

^a EGE UNIVERSITY   (Turkey)

^b Kutahya Evliya Celebi State Hospital   (Turkey)

Author keywords

Bioassay; Glycopeptides; Meningitis; MRSA; Pharmacokinetics; Staphylococcus aureus; Teicoplanin

Indexed keywords

ANTIINFECTIVE AGENT; TEICOPLANIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL MENINGITIS; BACTERIAL STRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BLOOD LEVEL; EXPERIMENTAL INFECTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; RABBIT; STATISTICAL SIGNIFICANCE; TIME SERIES ANALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; MALE; MENINGITIS, BACTERIAL; METHICILLIN RESISTANCE; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; VANCOMYCIN;

EID: 26944445824     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.08.011     Document Type: Article

References (31)

1. M. Sunbul, S. Esen, and C. Eroglu Retrospective evaluation of 130 cases of meningitis Turk J Infect 13 1999 303 308
2. A.G. Jensen, F. Espersen, P. Skinhoj, V.T. Rosdahl, and N. Frimodt-Moller Staphylococcus aureus meningitis: a review of 104 nationwide consecutive cases Arch Intern Med 153 1993 1902 1908
3. V. Pintado, M.A. Meseguer, and J. Fortum Clinical study of Staphylococcus aureus meningitis Eur J Clin Microbiol Infect Dis 21 2002 864 868
4. W.N. Chang, C.H. Lu, and J.J. Wu Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains Infection 29 2001 245 250
5. C.H. Lu, and W.N. Chang Adults with meningitis caused by oxacillin-resistant Staphylococcus aureus Clin Infect Dis 31 2000 723 727
6. R. Quintilliani, and B.W. Cooper Current concepts in the treatment of staphylococcal meningitis J Antimicrob Chemother 21 Suppl. C 1988 107 112
7. D. Gur, S. Unal, and H.E. Akalin Resistance patterns in Turkey Int J Antimicrob Agents 6 1995 23 26
8. M. Namiduru, I. Karaoglan, S. Goksu, O. Dikensoy, and M. Karaoglan Causative bacteria in nosocomial infections in surgical intensive care unit and their resistance to antibiotics Turk J Infect 17 2003 39 44
9. K. Kralinsky, J. Lako, S. Dluholucky, and V. Krcmery Nosocomial staphylococcal meningitis in neonates successfully treated with intraventricular teicoplanin Chemotherapy 45 1999 313 314
10. M. Cruciani, A. Navara, and G.D. Peri Evaluation of intraventricular teicoplanin for the treatment of neurosurgical shunt infections Clin Infect Dis 15 1992 285 289
11. B. Arda, T. Yamazhan, O.R. Sipahi, S. Islekel, C. Buke, and S. Ulusoy Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of ten cases Int J Antimicrob Agents 25 2005 414 418
12. M. Venditti, A. Micozzi, P. Serra, G. Buniva, L. Palma, and P. Martino Intraventricular administration of teicoplanin in shunt associated ventriculitis caused by methicillin resistant Staphylococcus aureus J Antimicrob Chemother 21 1988 513 515
13. B.M. Suntur, T. Yurtseven, O.R. Sipahi, C. Buke, and M. Buke Rifampicin + ceftriaxone versus vancomycin + ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model Int J Antimicrob Agents 26 2005 258 260
14. K. Chapin-Robertson, and S.C. Edberg Measurements of antibiotics in human body fluids: techniques and significance V. Lorian Antibiotics in laboratory medicine 3rd ed. 1991 Williams Wilkins Baltimore, MD 295 366
15. R.C. Erickson, A.R. Hildebrand, P.F. Hoffman, and C.B. Gibson A sensitive bioassay for teicoplanin in serum in the absence or presence of other antibiotics Diagn Microbiol Infect Dis 12 1989 235 241
16. M. Pfaller, D.J. Krogstad, G.G. Granich, and P.R. Murray Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay and fluorescence immunoassay J Clin Microbiol 20 1984 311 316
17. S. Ulusoy, I. Erdem, Ö. Dirim, G. Karakartal, and C. Gunhan Acute bacterial meningitis in adults: evaluation of 148 cases Turk J Infect 9 1995 27 31
18. G. Karakartal, C. Gunhan, and M. Buke Cases of meningitis in Izmir and vicinity 1974-1986 Turk J Infect 1 1987 1 4
19. T. Yamazhan, B. Arda, M. Tasbakan, D. Gokengin, S. Ulusoy, and D. Serter Analysis of 94 cases with acute purulent meningitis KLIMIK Dergisi 17 2004 95 98
20. B. Arda, O.R. Sipahi, S. Atalay, and S. Ulusoy Türkiye'de Akut Bakteriyel menenjitler Konusunda yayinlanmiş Çalişmalarin Deǧerlendirilmesi Program and Abstracts of the 30th Turkish Microbiology Congress; Kuşadasi, Aydin 2004 Turkish Microbiology Association Istanbul, Turkey 251 [Abstract S2-8]
21. T. Sakamoto, K. Kikuchi, K. Mineura, M. Kowada, and O. Nakagomi MRSA meningitis in postoperative patients. Report of 4 cases Jpn J Antibiot 43 1990 1137 1142
22. R.C. Moellering Pharmacokinetics of vancomycin J Antimicrob Chemother 14 Suppl. d 1984 43 52
23. J.P. Stahl, J. Croize, and M. Wolff Poor penetration of teicoplanin into cerebral fluid in patients with bacterial meningitis J Antimicrob Chemother 20 1987 141 142
24. D.D. Lee, R. Maserati, and W.M. Scheld Evaluation of teicoplanin in experimental Staphylococcus aureus meningitis Program and Abstracts of the 20th Interscience Conference on Antimicrobial Agents and Chemotherapy; Washington DC 1985 American Society for Microbiology Washington, DC [Abstract p689]
25. H. Lee, J.H. Song, and S.W. Kim Evaluation of a triple-drug combination for treatment of experimental multidrug-resistant pneumococcal meningitis Int J Antimicrob Agents 23 2004 307 310
26. M. Wenk, S. Vozeh, and F. Follath Serum level monitoring of antibacterial drugs: a review Clin Pharmacokinet 9 1984 475 492
27. K.S. Kim, J.H. Kang, and A.S. Bayer Efficacy of teicoplanin in experimental group B streptococcal bacteremia and meningitis Chemotherapy 33 1987 177 182
28. P.R. Wilson Clinical pharmacokinetics of teicoplanin Clin Pharmacokinet 39 2000 167 183
29. A.P. Macgowan Pharmacodynamics, pharmacokinetics and therapeutic drug monitoring of glycopeptides Ther Drug Monit 20 1998 473 477
30. A. Fernandez, C. Cabellos, and F. Tubau Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis J Antimicrob Chemother 55 2005 78 83
31. D.W. Galetto, J.A. Bosoia, D.W. Kobasa, and D. Kaye Teicoplanin compared with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis J Infect Dis 154 1986 69 75